$266 Million is the total value of DAFNA Capital Management LLC's 89 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 20.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $48,019,000 | +21.0% | 13,680,554 | 0.0% | 18.06% | +21.1% | |
| SAGE | Buy | SAGE THERAPEUTICS INC | $17,509,000 | -22.8% | 124,806 | +0.8% | 6.58% | -22.7% |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $11,995,000 | +60.2% | 636,013 | 0.0% | 4.51% | +60.3% | |
| BPMC | BLUEPRINT MEDICINES CORP | $9,053,000 | -22.1% | 123,218 | 0.0% | 3.40% | -22.1% | |
| GLPG | GALAPAGOS NVspon adr | $8,016,000 | +18.4% | 52,509 | 0.0% | 3.02% | +18.5% | |
| ATRC | ATRICURE INC | $7,949,000 | -16.4% | 318,729 | 0.0% | 2.99% | -16.4% | |
| FATE | Buy | FATE THERAPEUTICS INC | $7,299,000 | +498.8% | 470,000 | +682.9% | 2.74% | +499.3% |
| CARA | Buy | CARA THERAPEUTICS INC | $6,927,000 | +57.1% | 378,924 | +84.8% | 2.60% | +57.2% |
| IBB | Buy | ISHARES TR NASDAQ BIOTECHetf | $6,458,000 | -3.6% | 64,900 | +5.7% | 2.43% | -3.5% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $5,825,000 | -14.8% | 60,480 | +1.9% | 2.19% | -14.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $5,813,000 | +6.6% | 64,508 | -0.2% | 2.19% | +6.6% |
| ZGNX | Buy | ZOGENIX INC | $5,716,000 | -15.0% | 142,764 | +1.4% | 2.15% | -15.0% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $5,531,000 | -8.9% | 287,748 | +40.1% | 2.08% | -8.9% |
| DXCM | DEXCOM INC | $5,423,000 | -0.4% | 36,338 | 0.0% | 2.04% | -0.3% | |
| CYTK | Sell | CYTOKINETICS INC | $4,765,000 | -11.2% | 418,727 | -12.3% | 1.79% | -11.2% |
| ARNA | ARENA PHARMACEUTICALS INC | $4,300,000 | -21.9% | 93,942 | 0.0% | 1.62% | -21.9% | |
| LMNX | Buy | LUMINEX CORP | $4,214,000 | +5.2% | 204,091 | +5.2% | 1.58% | +5.2% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $4,090,000 | – | 169,800 | +100.0% | 1.54% | – |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $4,056,000 | -28.5% | 197,554 | -9.2% | 1.52% | -28.5% |
| BHVN | BIOHAVEN PHARMACEUTICALS HOLD | $3,963,000 | -4.7% | 95,000 | 0.0% | 1.49% | -4.7% | |
| MNLO | Buy | MENLO THERAPEUTICS INC | $3,839,000 | +6.8% | 856,936 | +42.8% | 1.44% | +6.9% |
| ARQL | Buy | ARQULE INC | $3,802,000 | -30.6% | 530,262 | +6.5% | 1.43% | -30.6% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,665,000 | +1.1% | 4,000,000 | 0.0% | 1.38% | +1.2% | ||
| TBIO | Buy | TRANSLATE BIO INC | $3,610,000 | +60.3% | 364,229 | +104.3% | 1.36% | +60.3% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $3,246,000 | -19.3% | 828,038 | -0.3% | 1.22% | -19.2% |
| XENE | XENON PHARMACEUTICALS INC | $2,979,000 | -8.6% | 330,667 | 0.0% | 1.12% | -8.6% | |
| ARDX | Sell | ARDELYX INC | $2,728,000 | +48.7% | 580,524 | -14.8% | 1.03% | +48.9% |
| MGNX | Buy | MACROGENICS INC | $2,552,000 | +200.6% | 200,000 | +300.0% | 0.96% | +200.9% |
| ARGX | Sell | ARGENX SEsponsored adr | $2,504,000 | -44.3% | 21,969 | -30.8% | 0.94% | -44.3% |
| BLUE | BLUEBIRD BIO INC | $2,341,000 | -27.8% | 25,500 | 0.0% | 0.88% | -27.8% | |
| KDMN | KADMON HOLDINGS INC | $2,233,000 | +22.3% | 886,177 | 0.0% | 0.84% | +22.4% | |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $2,195,000 | -0.1% | 46,200 | -9.8% | 0.83% | 0.0% |
| ALEC | Buy | ALECTOR INC | $2,091,000 | +375.2% | 145,000 | +525.9% | 0.79% | +376.4% |
| ARAY | Buy | ACCURAY INC | $1,868,000 | -7.9% | 674,300 | +28.6% | 0.70% | -7.9% |
| BEAT | BIOTELEMETRY INC | $1,845,000 | -15.4% | 45,300 | 0.0% | 0.69% | -15.4% | |
| NVRO | Sell | NEVRO CORP | $1,823,000 | +7.3% | 21,210 | -19.1% | 0.69% | +7.4% |
| CBAY | CYMABAY THERAPEUTICS INC | $1,792,000 | -28.5% | 349,996 | 0.0% | 0.67% | -28.5% | |
| ARCT | Buy | ARCTURUS THERAPEUTICS HLDG I | $1,786,000 | +7665.2% | 173,914 | +7146.4% | 0.67% | +7366.7% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $1,779,000 | – | 47,308 | +100.0% | 0.67% | – |
| DRNA | DICERNA PHARMACEUTICALS INC | $1,699,000 | -8.8% | 118,314 | 0.0% | 0.64% | -8.7% | |
| ELOX | ELOXX PHARMACEUTICALS INC | $1,695,000 | -54.7% | 375,000 | 0.0% | 0.64% | -54.7% | |
| ACHN | Sell | ACHILLION PHARMACEUTICALS | $1,580,000 | -2.5% | 438,884 | -27.4% | 0.59% | -2.5% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $1,573,000 | -45.4% | 542,564 | -26.1% | 0.59% | -45.3% |
| KURA | Buy | KURA ONCOLOGY INC | $1,572,000 | +69.0% | 103,658 | +119.4% | 0.59% | +68.9% |
| PRQR | PROQR THERAPEUTICS N V | $1,506,000 | -36.7% | 261,521 | 0.0% | 0.57% | -36.8% | |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $1,503,000 | -42.7% | 360,542 | +80.3% | 0.56% | -42.7% |
| AGTC | APPLIED GENETIC TECHNOL CORP | $1,494,000 | +9.8% | 359,190 | 0.0% | 0.56% | +9.8% | |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | $1,448,000 | -29.7% | 297,300 | 0.0% | 0.54% | -29.6% | |
| VKTX | VIKING THERAPEUTICS INC | $1,439,000 | -17.1% | 209,200 | 0.0% | 0.54% | -17.2% | |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $1,385,000 | -11.0% | 483,388 | +17.6% | 0.52% | -10.9% |
| NTUS | NATUS MEDICAL INC | $1,366,000 | +24.0% | 42,900 | 0.0% | 0.51% | +24.2% | |
| SCYX | SCYNEXIS INC | $1,356,000 | -18.7% | 1,272,927 | 0.0% | 0.51% | -18.7% | |
| EPZM | Sell | EPIZYME INC | $1,258,000 | -42.2% | 121,986 | -29.7% | 0.47% | -42.2% |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $1,242,000 | -22.9% | 100,000 | 0.0% | 0.47% | -22.8% | |
| JNJ | JOHNSON AND JOHNSON | $1,216,000 | -7.1% | 9,400 | 0.0% | 0.46% | -7.1% | |
| GMDA | Sell | GAMIDA CELL LTD | $1,182,000 | -15.4% | 272,909 | -0.8% | 0.44% | -15.2% |
| INGN | INOGEN INC | $1,102,000 | -28.2% | 23,000 | 0.0% | 0.41% | -28.2% | |
| SYBX | New | SYNLOGIC INC | $991,000 | – | 432,830 | +100.0% | 0.37% | – |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $929,000 | -51.7% | 305,500 | -62.2% | 0.35% | -51.7% |
| PRVL | PREVAIL THERAPEUTICS INC | $921,000 | -7.0% | 75,000 | 0.0% | 0.35% | -7.0% | |
| BTAI | New | BIOXCEL THERAPEUTICS INC | $898,000 | – | 127,500 | +100.0% | 0.34% | – |
| STIM | New | NEURONETICS INC | $883,000 | – | 106,247 | +100.0% | 0.33% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $793,000 | -28.9% | 501,736 | +82.3% | 0.30% | -28.9% |
| CTMX | New | CYTOMX THERAPEUTICS INC | $738,000 | – | 100,000 | +100.0% | 0.28% | – |
| DERM | DERMIRA INC | $665,000 | -33.1% | 104,000 | 0.0% | 0.25% | -33.2% | |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $663,000 | – | 920,995 | +100.0% | 0.25% | – |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $569,000 | -17.8% | 6,600 | 0.0% | 0.21% | -17.7% | |
| RDUS | RADIUS HEALTH INC | $567,000 | +5.8% | 22,000 | 0.0% | 0.21% | +6.0% | |
| OBSV | Buy | OBSEVA SA | $535,000 | -5.1% | 64,231 | +28.9% | 0.20% | -5.2% |
| INSM | INSMED INC | $529,000 | -31.1% | 30,000 | 0.0% | 0.20% | -31.1% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $497,000 | -27.1% | 50,573 | 0.0% | 0.19% | -27.0% | |
| MASI | MASIMO CORPORATION | $446,000 | 0.0% | 3,000 | 0.0% | 0.17% | 0.0% | |
| GRTS | GRITSTONE ONCOLOGY INC | $432,000 | -22.4% | 50,000 | 0.0% | 0.16% | -22.5% | |
| SPRO | Sell | SPERO THERAPEUTICS INC | $418,000 | -48.1% | 39,395 | -43.7% | 0.16% | -48.2% |
| DEXCOM INCnote 0.750% 5/1 | $397,000 | -0.5% | 250,000 | 0.0% | 0.15% | -0.7% | ||
| STRO | Buy | SUTRO BIOPHARMA INC | $364,000 | +1.7% | 40,000 | +27.0% | 0.14% | +1.5% |
| URGN | UROGEN PHARMA LTD | $357,000 | -33.8% | 15,000 | 0.0% | 0.13% | -34.0% | |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $295,000 | -17.8% | 157,700 | +14.6% | 0.11% | -17.8% |
| KALV | KALVISTA PHARMACEUTICALS INC | $287,000 | -47.6% | 24,725 | 0.0% | 0.11% | -47.6% | |
| ALDX | ALDEYRA THERAPEUTICS INC | $264,000 | -12.0% | 50,000 | 0.0% | 0.10% | -12.4% | |
| ZFGN | Buy | ZAFGEN INC | $226,000 | -33.5% | 305,500 | +7.0% | 0.08% | -33.6% |
| BLCM | Buy | BELLICUM PHARMACEUTICALS INC | $210,000 | +311.8% | 200,000 | +566.7% | 0.08% | +315.8% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $199,000 | -44.3% | 99,993 | -53.0% | 0.08% | -44.0% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $183,000 | -8.5% | 11,192 | +11.9% | 0.07% | -8.0% |
| EVLO | New | EVELO BIOSCIENCES INC | $122,000 | – | 20,000 | +100.0% | 0.05% | – |
| ADXS | New | ADVAXIS INC | $93,000 | – | 350,000 | +100.0% | 0.04% | – |
| LCTX | New | LINEAGE CELL THERAPEUTICS IN | $93,000 | – | 95,000 | +100.0% | 0.04% | – |
| ALRN | AILERON THERAPEUTICS INC | $67,000 | -6.9% | 99,502 | 0.0% | 0.02% | -7.4% | |
| ORMP | ORAMED PHARMACEUTICALS INC | $51,000 | -10.5% | 16,000 | 0.0% | 0.02% | -9.5% | |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -6,265 | -100.0% | -0.04% | – |
| BTX | Exit | BIOTIME INC | $0 | – | -95,000 | -100.0% | -0.04% | – |
| Exit | ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $0 | – | -250,000 | -100.0% | -0.09% | – | |
| SLGL | Exit | SOL GEL TECHNOLOGIES LTD | $0 | – | -35,000 | -100.0% | -0.12% | – |
| MORF | Exit | MORPHIC HOLDING INC | $0 | – | -60,000 | -100.0% | -0.45% | – |
| NXTC | Exit | NEXTCURE INC | $0 | – | -96,100 | -100.0% | -0.54% | – |
| Exit | INTEC PHARMA LTD JERUSALEM | $0 | – | -415,989 | -100.0% | -0.68% | – | |
| CRTX | Exit | CORTEXYME INC | $0 | – | -65,400 | -100.0% | -1.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.